Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2005

Clinicopathological Features of Lupus Anticoagulant: Experience at AFIP During Last Seven Years

Muhammad Ayyub, M Khan, Masood Anwar, Amin Waqar, Waqar Ali, Tassawar Hussain, Muhammad Luqman, Nadira Sultana, Karamat Karamat, Wasif Saif

Med Sci Monit 2005; 11(11): CR536-539 :: ID: 430368

Abstract

Background: The lupus anticoagulant (LA) belongs to family of immunoglobulins,most commonly an IgG isotype. These antibodies have been identified most frequently in association withthromboembolic events, recurrent fetal loss and thrombocytopenia. The aim of the present study was toevaluate the presenting clinical and pathological features in patients LA positive presenting at AFIPRawalpindi over the period of Jan 1993 to Nov 2000. Material/Methods: Retrospective analysis of patientspresenting with positive LA was carried out. Results: 1583 suspected cases were screened for LA including1370 females and 213 males. 1024 cases presented with history of recurrent abortions, 292 with thrombosis,152 with thrombotic strokes before the age of 45 years, 52 with thrombocytopenia and 63 with miscellaneousdisorders. Out of 1024 patients tested for recurrent abortions, 130 (13%) females were positive for lupusanticoagulant. Ten (6.5%) of 152 patients presenting with strokes were found positive. Out of 292 casespresenting with thrombosis 17 (5.9%) were found positive. Conclusions: The lupus anticoagulant prevalencein Pakistani patients with recurrent fetal loss, stroke and thrombosis is statistically significant.Clinicians should be made aware of association of LA with various diseases. The successful managementof these patients depends upon close liaison with obstetricians, physicians and haematologists.

Keywords: Antiphospholipid Syndrome - diagnosis, Abortion, Habitual - immunology, Lupus Coagulation Inhibitor - analysis, Pregnancy, Stroke - immunology, Thromboembolism - immunology

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750